OTC · Drug Manufacturers - General

Haw Par Corporation Limited (HAWPY) Stock

$53.50 +0.00% OTC: HAWPY Healthcare

Haw Par Corporation Limited, through its numerous subsidiaries, engages in the creation, distribution, and sale of healthcare products across Singapore, the ASEAN region, other Asian nations, and internationally. Its business is structured into three main divisions: Healthcare, Investments, and a general "Others" category.

Valuation

MetricValue
Price$53.50
Market Cap$2.96B
P/E Ratio13.52
P/B Ratio0.84
P/S Ratio15.61
EPS (TTM)$3.96
52-Week High$54.44
52-Week Low$28.64
Dividend Yield1.16%

Financials & Margins

MetricValue
ROE6.34%
ROA6.01%
ROCE1.56%
Gross Margin55.99%
Operating Margin29.17%
Net Margin115.43%
Debt/Equity0.01
Current Ratio7.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$141.0M$182.0M$232.0M$245.0M$226.0M
Operating Profit$25.0M$43.0M$64.0M$64.0M$66.0M
Net Profit$110.0M$148.0M$217.0M$228.0M$261.0M
EPS$2.00$2.68$3.92$4.12$4.72
Op Margin17.5%23.8%27.6%26.1%29.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.3B$3.6B$3.6B$4.3B$4.4B
Total Liabilities$72.0M$101.0M$117.0M$128.0M$127.0M
Cash$596.0M$334.0M$574.0M$746.0M$791.0M
Borrowings$2.0M$58.0M$28.0M$36.0M$44.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$19.0M$41.0M$63.0M$54.0M$267.0M
Investing Cash Flow$83.0M$-281.0M$250.0M$196.0M$74.0M
Financing Cash Flow$0$-1.0M$-2.0M$-2.0M$0
Net Cash Flow$42.0M$-262.0M$240.0M$172.0M$88.0M
Free Cash Flow$14.0M$21.0M$55.0M$50.0M$265.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.82
EV / EBITDA38.71
FCF Yield4.21%
Quick Ratio6.96
Interest Coverage44.05
Return 1Y91.35%
Return 3Y134.16%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APNHYAspen Pharmacare Holdings Limited $8.59 -4.98% -33.17 $3.81B 1.40%
BVNRYBavarian Nordic A/S $9.15 -0.65% 12.33 $2.12B 0.00%
CHSYFChina Medical System Holdings Limited $1.57 +0.00% 17.84 $3.80B 2.55%
GGNDFGN Store Nord A/S $13.39 +0.00% -35.71 $1.95B 0.00%
GNNDYGN Store Nord A/S $41.99 -1.40% -35.71 $2.04B 0.00%

About Haw Par Corporation Limited

Haw Par Corporation Limited, through its numerous subsidiaries, engages in the creation, distribution, and sale of healthcare products across Singapore, the ASEAN region, other Asian nations, and internationally. Its business is structured into three main divisions: Healthcare, Investments, and a general "Others" category. The Healthcare segment's primary focus is on manufacturing and supplying topical analgesic remedies, notably the prominent Tiger Balm and Kwan Loong brands. The Investments division concentrates predominantly on financial investments, specifically in publicly listed securities. Additionally, the company manages and rents out a substantial portfolio of investment properties, offering 45,324 square meters of commercial and industrial space in Singapore and Malaysia. It also provides family-oriented and tourist leisure options, mainly through its oceanariums. Furthermore, Haw Par Corporation leases land, buildings, and office spaces, and extends management support services. The company was founded in Singapore in 1969 and continues to operate from its base there.

Haw Par Corporation Limited is headquartered in SG.

Haw Par Corporation Limited (HAWPY) stock trades at $53.50 with a market capitalization of $2.96B. The stock is valued at a price-to-earnings (P/E) ratio of 13.52, price-to-book of 0.84, price-to-sales of 15.61. Over the past 52 weeks the stock has ranged between $28.64 and $54.44, and currently trades 1.7% below its 52-week high. It pays a dividend yielding 1.16%.

On profitability, Haw Par Corporation Limited generates a return on equity (ROE) of 6.34%, return on capital employed of 1.56%, an operating margin of 29.17%, a net profit margin of 115.43%.

Official website: www.hawpar.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides